aTyr Pharma Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, aTyr Pharma stock has a consensus rating of "Buy" and an average price target of $2.86. The average 1-year stock price forecast is 344.72% higher than the current stock price, while the lowest is $1.00 (+55.50%) and the highest is $7.00 (+988.48%).

Price Target: $2.86 (+344.72%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.00	$2.86	$3.00	$7.00
Change	+55.50%	+344.72%	+366.49%	+988.48%

* Price targets were last updated on May 20, 2026.

Analyst Ratings

The average analyst rating for aTyr Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	1	1	2	2
Buy	2	2	2	2	2	2
Hold	7	7	6	6	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Boris Peaker JonesTrading	JonesTrading	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jun 29, 2026
Ilya Zubkov Freedom Capital Markets	Freedom Capital Markets	Buy Upgrades $1 → $3.5	Buy	Upgrades	$1 → $3.5	+444.24%	May 20, 2026
Derek Archila Wells Fargo	Wells Fargo	Hold Reiterates $1	Hold	Reiterates	$1	+55.50%	May 18, 2026
Brian Abrahams RBC Capital	RBC Capital	Hold Maintains $1	Hold	Maintains	$1	+55.50%	May 15, 2026
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $20	Buy	Maintains	$20	+3,009.94%	May 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 190.00K

-100.00%

from 190.00K

Revenue Next Year

n/a

EPS This Year

-0.54

from -0.80

EPS Next Year

-0.64

from -0.54

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	10.39M	353.00K	235.00K	190.00K	-
Revenue Growth	-	-	-96.60%	-33.43%	-19.15%	-100.00%
Operating Income	-34.02M	-46.40M	-54.92M	-67.91M	-77.63M	-55.83M
Net Income	-33.77M	-45.34M	-50.39M	-64.02M	-74.12M	-54.01M
EPS	-	-	-	-	-0.80	-0.54
Free Cash Flow	-20.32M	-27.93M	-21.18M	-44.36M	-33.80M	-57.00M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-100.0%
Avg	-100.0%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.47
Avg	-0.54
Low	-0.63

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-